Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Immunotherapy for cancer in the central nervous system: Current and future directionsUnderground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsNovel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)Understanding the role of the kynurenine pathway in human breast cancer immunobiologyImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerTrial watch: IDO inhibitors in cancer therapySuppression, subversion and escape: the role of regulatory T cells in cancer progressionThe Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for ImmunotherapySignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyLymphoma: immune evasion strategiesThe IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cellsImmunological Relevance of the Coevolution of IDO1 and AHRSimultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancerLeukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia.Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.Regulatory T Cells in Allergy and Asthma.Induction of Th1Immune responses following laser ablation in a murine model of colorectal liver metastases.Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression.In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.Opportunities and limitations of natural killer cells as adoptive therapy for malignant diseaseIDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitisGM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms.Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease.Contribution of bone microenvironment to leukemogenesis and leukemia progression.Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasisRegulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3.Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugsMurine models of B-cell lymphomas: promising tools for designing cancer therapiesThe Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.Recent developments on immunotherapy for brain cancer.Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners
P2860
Q26746104-E4FBB392-4595-4B95-8B90-32366D36821AQ26750765-FF5924DF-6FEC-410B-9F09-6BF343418568Q26751011-98010748-B68B-4740-8BF5-2AB05EF730B6Q26770391-7DBD8789-E47F-4A58-925D-F44DE92BB295Q26773472-849D3D79-2BE9-4DF9-86E0-53D6E659447CQ26996829-F1238906-26DE-4ABC-B55F-10E67420FEB4Q27006866-B3DD9609-CF06-4674-987C-59DACF78DC42Q27026151-09DD53E9-E354-440B-99A6-88C6892A3FB2Q28073631-FE9892FD-4A03-4A44-8E2A-3C62261384EDQ28080262-85B48CDA-48CE-41A0-96E1-4A06C63DE33CQ28080705-BBDE5759-8F78-4C2D-A07B-F425175284DBQ28275608-FAC20708-3CE0-47FE-8CF1-68D61DB0F4F1Q28654567-644B9FCB-7A68-4CA0-B1A1-90E3C4A75520Q33482453-F06F1AB5-233C-4033-80FE-A9F1AF0BB2B2Q33558780-922228E6-1BD8-4C76-9FF5-442F6BB85D10Q33613674-5C56EC59-56E9-433F-8C02-48D1D8169CBCQ33660069-F1B6BB02-18C9-41FD-AF1E-FD1615470CA7Q33688517-BD3F8FE2-53A4-4F42-9873-ECDCD7DA5F02Q33707435-6FB60FF3-E552-4A3B-A09B-9C935DF17DECQ33715605-620AC155-7AF8-4AAB-9B6E-6AD3CA168A2DQ33914458-E241DDE6-550A-45D2-9530-3EF26D8DA37BQ33919954-4739950B-CD00-409C-8EF1-10653D59219BQ33978035-B5B62DD5-FC9F-492D-81E8-3D6E1A2F3A8EQ34154994-49824003-D3A1-425A-98E7-E864A5E916B8Q34219774-B5A25BAA-E0BF-4398-BD01-321755F4E727Q34307792-28BC1AA7-4735-4F1A-B160-DC1EEC646C8EQ34389464-B9787111-10FD-407A-A90F-B00162F88BF9Q34510143-66BC5CBF-85FE-43EA-96F7-CADBD248D699Q34601368-DEDAB54E-B246-498E-BF76-9DE4750D1478Q35037058-AD97756C-43CA-4AE5-B2E9-1550A660D9A6Q35248373-77D9476A-7F88-4994-A322-52A3F7AF2C3AQ35450360-7FB2E025-FDCF-4584-A5EE-B71D35900E92Q35553553-F50D4FE4-E23C-4677-A084-0964E42DBF2CQ35632079-310DFC75-425D-4AE3-B42E-9DE689F35FC1Q35753251-BEA147ED-718F-49CF-8004-909761F7A677Q35757397-3FEA1B89-1CF4-419B-B23F-3F58AD65E856Q35779492-E884F3A2-1141-407F-AD9B-D35CA7467D45Q35884237-2D1CA8B4-EEE4-4694-9047-D879B134D61DQ35992355-7F8013C3-83BA-4C03-9310-C580BABCCEA0Q36018275-F0856692-E7C5-4EA7-A7C9-89A92CE6A03F
P2860
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Modulation of tryptophan catab ...... into CD25+ T regulatory cells.
@en
type
label
Modulation of tryptophan catab ...... into CD25+ T regulatory cells.
@en
prefLabel
Modulation of tryptophan catab ...... into CD25+ T regulatory cells.
@en
P2093
P50
P1433
P1476
Modulation of tryptophan catab ...... into CD25+ T regulatory cells.
@en
P2093
Alberto L Horenstein
Antonio Curti
Barbara Valzasina
Elisa Ferri
Francesca Fiore
Giuseppina Bonanno
Ilaria Durelli
Michela Aluigi
Roberto M Lemoli
Simona Pandolfi
P304
P356
10.1182/BLOOD-2006-07-036863
P407
P577
2007-04-01T00:00:00Z